Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 2 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar pchop123 (79.82) Submitted: 12/4/2012 4:56:38 PM : Underperform Start Price: $24.77 INFI Score: -14.22

Poised to disappoint possibly

Featured Broker Partners


Advertisement